News
Application of Skanska by the Arnhem-Leeuwarden Court of Appeal
On 26 November the Arnhem-Leeuwarden Court of Appeal applied the Skanska judgment of the ECJ to establish liability of a subsidiary for damages as a result of a breach of EU competition law. The decision stems from a follow-on damages action of TenneT in the gas-insulated switch gear cartel. In these proceedings TenneT not only
Read more ›
BarentsKrans acts as independent advisor in relation to the investment in NewCompliance
BarentsKrans has acted as independent advisor for NewCompliance B.V., its founders and investors InnovationQuarter and Noaber Ventures during this transaction. BarentsKrans often acts as independent advisor in order to ensure that the transaction process is efficient and smooth. The scale-up NewCompliace has obtained an investment of USD 3 million to finance its expansion to the
Read more ›
BarentsKrans advises on the sell side of the acquisition of Dearnova
BarentsKrans has advised on the sell side of the acquisition of Dearnova by We are you. Dearnova has been incorporated in 2000 and currently employs over 70 professionals. The digital agency helps top players within the Netherlands such as PostNL, VodafoneZiggo, Schiphol and Telegraaf Media Groep. Each a top player in a different segment. We
Read more ›
BarentsKrans advises on the sell side of the acquisition of Royal Sens
BarentsKrans has advised on the sell side of the acquisition of Royal Sens by private equity firm Quadrum Capital. Quadrum Capital is a nationally operating investment company with offices in central and eastern Netherlands. Quadrum Capital has a strong entrepreneurial mentality and a broad portfolio of investments in various sectors. The packaging industry is one
Read more ›
The Dutch Authority for the Financial Markets (AFM) and the Dutch Central Bank (DNB) identify best practices for alternative interest rate benchmarks
From 1 January 2022 onwards, the Benchmark Regulation (2016/1011/EU) will be directly applicable in each member state of the European Union. As a result, certain crucial interest rate benchmarks, such as EURIBOR, LIBOR and EONIA, shall not be admissible in its current form. From that point on, new financial agreements and, in principle, also existing
Read more ›
Joost Fanoy will speak during Annual Business Law Forum
Joost Fanoy will speak this Friday on a panel on damages claims in E-commerce cases during the 10th Annual Business Law Forum in Vienna of the International Association of Lawyers (UIA). The panel will focus on new trends in damages cases (e.g. resale price maintenance, geoblocking violations, abuse of market dominance, unfair competition violations, experience
Read more ›
Telecoms update: ‘Better Network’ campaign KPN not unlawful, rules District Court
Our Telecoms Update of 30 July 2019 is about the recent decision of the The Hague District Court in KPN v T-Mobile. The Court ruled that KPN’s advertising campaign ‘Better Network, Better Life’ did not constitute unlawful comparative advertising and rejected T-Mobile claims in full. The judgment means that KPN is allowed to continue its very successful advertising campaign. BarentsKrans represented KPN in this case.
Read more ›
Telecoms update: The Hague Court of Appeal injuncts another unwilling licensee
Less than two months after the decision in Philips/Asustek, the The Hague Court of Appeal again grants an injunction against a SEP-user. Following the interim decision in which the SEP invoked by Philips was declared valid and infringed, the Court of Appeal rendered a final decision on 2 July 2019 in which Wiko’s FRAND defence
Read more ›
BarentsKrans again recommended in leading IAM Patent 1000 ranking
The international rankings of ‘IAM Patent 1000’ comprise of an overview of the most prominent law firms in the field of patent law and patent litigation. The listing is composed by means of substantial research by IAM. Firms are assessed on aspects such as knowledge, market share and the quality of rendered services. The assessment
Read more ›
Pharma update: pemetrexed tromethamine does not infringe pemetrexed disodium patent
In its judgment of 19 June 2019, the District Court of The Hague ruled that Fresenius Kabi’s pemetrexed tromethamine falls outside the scope of protection of Eli Lilly’s patent for pemetrexed disodium. This final relief decision deviates from earlier decisions in interim relief proceedings and decisions by several foreign courts. Eli Lilly (“Lilly”) markets the
Read more ›
